Daiichi Sankyo To Join Growing Japan Market For Alzheimer's Drugs
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo is set to announce it is joining leading Japanese drug makers in marketing treatments for Alzheimer's disease